889953-29-1 Usage
Uses
Used in Pharmaceutical Industry:
3-(2-Carboxy-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a building block for the synthesis of various drugs and biologically active molecules. Its versatility in drug design and synthesis makes it a valuable component in the development of new pharmaceuticals.
Used in Chemical Reactions:
3-(2-Carboxy-phenyl)-pyrrolidine-1-carboxylic acid tert-butyl ester is used as a protecting group for the carboxylic acid functionality during chemical reactions. The tert-butyl ester group can be removed later to reveal the original carboxylic acid group, allowing for further modifications and reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 889953-29-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,9,5 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 889953-29:
(8*8)+(7*8)+(6*9)+(5*9)+(4*5)+(3*3)+(2*2)+(1*9)=261
261 % 10 = 1
So 889953-29-1 is a valid CAS Registry Number.
889953-29-1Relevant academic research and scientific papers
MODIFIED PROTEINS AND PROTEIN DEGRADERS
-
, (2021/12/08)
Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
Synthesis method of 2-[3'-(N-Boc-pyrrolyl)]-benzoic acid
-
, (2019/12/25)
The invention belongs to the field of organic synthesis and discloses a synthesis method of 2-[3'-(N-Boc-pyrrolyl)]-benzoic acid. The synthesis method provided by the invention comprises the step of synthesizing the 2-[3'-(N-Boc-pyrrolyl)]-benzoic acid by
2-OXO-PIPERIDINYL DERIVATIVES
-
, (2013/04/25)
The present invention relates to 2-oxo-piperidinyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
